Literature DB >> 31259051

Absorption spectra of early stool from preterm infants need to be considered in abdominal NIRS oximetry.

Helene Isler1, Daniel Schenk2, Jérôme Bernhard2, Stefan Kleiser1, Felix Scholkmann1, Daniel Ostojic1, Alexander Kalyanov1, Linda Ahnen1, Martin Wolf1, Tanja Karen1.   

Abstract

Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency of the preterm infant. Low abdominal tissue oxygen saturation (StO2) measured by near-infrared spectroscopy (NIRS) oximetry may be an early sign of NEC relevant for treating or even preventing NEC. However, current commercial NIRS oximeters provide inaccurate StO2 readings because they neglect stool as an abdominal absorber. To tackle this problem, we determined the optical properties of faeces of preterm infants to enable a correct abdominal StO2 measurement. In 25 preterm born infants (median age 31 0/7 ± 2 1/7 weeks, weight 1478 ± 511 g), we measured their first five stool probes with a VIS/NIR spectrometer and calculated the optical properties using the Inverse Adding Doubling (IAD) method. We obtained two absorption spectra representing meconium and transitional stool. Probabilistic cluster analysis correctly classified 96 out of 107 stool probes. The faeces spectra need to be considered to enable correct abdominal StO2 measurements with NIRS oximetry.

Entities:  

Year:  2019        PMID: 31259051      PMCID: PMC6583346          DOI: 10.1364/BOE.10.002784

Source DB:  PubMed          Journal:  Biomed Opt Express        ISSN: 2156-7085            Impact factor:   3.732


  2 in total

1.  Osteopathic Manipulation Treatment Improves Cerebro-splanchnic Oximetry in Late Preterm Infants.

Authors:  Benedetta Marinelli; Francesca Pluchinotta; Vincenzo Cozzolino; Gina Barlafante; Maria Chiara Strozzi; Eleonora Marinelli; Simone Franchini; Diego Gazzolo
Journal:  Molecules       Date:  2019-09-04       Impact factor: 4.411

Review 2.  Emerging prediction methods for early diagnosis of necrotizing enterocolitis.

Authors:  Siyuan Wu; Sijia Di; Tianjing Liu; Yongyan Shi
Journal:  Front Med (Lausanne)       Date:  2022-09-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.